Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study
- 1 March 2000
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 46 (4), 903-911
- https://doi.org/10.1016/s0360-3016(99)00478-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Radiotherapy and 5-FU after curative resection for the cancer of the pancreas and peri-ampullary region: A phase III trial of the EORTC GITCCGEuropean Journal Of Cancer, 1997
- Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasmsThe American Journal of Surgery, 1994
- Results of resection for cancer of the exocrine pancreas: A study from the French Association of SurgeryBritish Journal of Surgery, 1994
- Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracilInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Enhancement of the antitumor effects of 5-fluorouracil by folinic acidPharmacology & Therapeutics, 1990
- Survival After PancreatoduodenectomyAnnals of Surgery, 1990
- Treatment of Locally Unresectable Carcinoma of the Pancreas: Comparison of Combined-Modality Therapy (Chemotheraphy Plus Radiotherapy) to Chemotheraphy Alone1JNCI Journal of the National Cancer Institute, 1988
- Collective Review of Small Carcinomas of the PancreasAnnals of Surgery, 1986
- COMBINED 5-FLUOROURACIL AND SUPERVOLTAGE RADIATION THERAPY OF LOCALLY UNRESECTABLE GASTROINTESTINAL CANCERThe Lancet, 1969
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958